检索结果 - Peter MacCallum
- Showing 1 - 11 results of 11
-
1
-
2
-
3
Thirty‐day mortality with andexanet alfa compared with prothrombin complex concentrate therapy for life‐threatening direct oral anticoagulant‐related bleeding 由 Alexander T. Cohen, Megan A. Lewis, Augusta Connor, Stuart J. Connolly, Patrick Yue, John T. Curnutte, Raza Alikhan, Peter MacCallum, Joachim Tan, Laura Green
出版 2022Artigo -
4
A three-year prospective study of the presentation and clinical outcomes of major bleeding episodes associated with oral anticoagulant use in the UK (ORANGE study) 由 Laura Green, Joachim Tan, Joan K. Morris, Raza Alikhan, Nicola Curry, Tamara Everington, Rhona Maclean, Khalid Saja, Simon Stanworth, Robert C. Tait, Peter MacCallum
出版 2018Artigo -
5
-
6
Respiratory Viruses, Symptoms, and Inflammatory Markers in Acute Exacerbations and Stable Chronic Obstructive Pulmonary Disease 由 Terence Seemungal, RHIAN HARPER-OWEN, Angshu Bhowmik, Ivana Morić, Gwendolyn Sanderson, Simon D. Message, Peter MacCallum, THOMAS W. MEADE, Donald J. Jeffries, Sebastian L. Johnston, Jadwiga A. Wedzicha
出版 2001Artigo -
7
-
8
Recreational nitrous oxide and thrombotic events: a case series 由 Marta Patyjewicz, D D Mair, Safiya A Zaloum, Barbara Onen, Joseph P. Walton, Ruth Dobson, Christine Joerres, Apeksha Madhusudan Shah, Peter MacCallum, Thomas H. Massey, Tadbir K. Bariana, Veronica White, Sarah A De Freitas, Alastair Noyce
出版 2024Artigo -
9
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D) 由 Annie Young, Andrea Marshall, Jenny Thirlwall, Oliver Chapman, Anand Lokare, Catherine St. Hill, Danielle Hale, Janet Dunn, Gary H. Lyman, Charles Hutchinson, Peter MacCallum, Ajay K. Kakkar, Richard Hobbs, Stavros Petrou, Jeremy Dale, Christopher Poole, Anthony Maraveyas, Mark N. Levine
出版 2018Artigo -
10
Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, control... 由 Frank Cools, Saverio Virdone, J.P.S. Sawhney, Renato D. Lópes, Barry Jacobson, Juan I. Arcelus, Richard Hobbs, Harry Gibbs, Jelle C.L. Himmelreich, Peter MacCallum, Sebastian Schellong, Sylvia Haas, Alexander G.G. Turpie, Walter Ageno, Ana Thereza Rocha, Gloria Kayani, Karen S. Pieper, Ajay K. Kakkar, Ajit Avhad, Murillo de Oliveira Antunes, Ana Thereza Rocha, Jesus Gonzales Lama, Atul Abyankar, Adrian Kormann, Louis van Zyl, Upendra Kaul, Frances Adams, Ivan Aloysius, Matthew Capehorn, Pradeep Kumar, Rajesh Mahajan
出版 2022Artigo -
11
Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials 由 Stefano Barco, Saverio Virdone, Andrea Götschi, Walter Ageno, Juan I. Arcelus, Roland Bingisser, Giuseppe Colucci, Frank Cools, Daniel Duerschmied, Harry Gibbs, Riccardo M. Fumagalli, B. Gerber, Sylvia Haas, Jelle C.L. Himmelreich, Richard Hobbs, Lukas Hobohm, Barry Jacobson, Gloria Kayani, Renato D. Lópes, Peter MacCallum, Evy Micieli, Marc Righini, Helia Robert‐Ebadi, Ana Thereza Rocha, Thomas Rosemann, Jitendra P Sawhney, Sebastian Schellong, Tim Sebastian, David Spirk, Stefan Stortecky, Alexander G.G. Turpie, Davide Voci, Nils Kucher, Karen S. Pieper, Ulrike Held, Ajay K. Kakkar
出版 2023Artigo
相关主题
Medicine
Internal medicine
Surgery
Thrombosis
Atrial fibrillation
Confidence interval
Randomized controlled trial
Rivaroxaban
Warfarin
Ambulatory
Anticoagulant
Coagulation
Emergency medicine
Immunology
Intensive care medicine
Low molecular weight heparin
Pathology
Prospective cohort study
Prothrombin time
Relative risk
2019-20 coronavirus outbreak
Adverse effect
Anesthesia
Anthropology
Antibody
Apixaban
Bleed
COPD
Cancer
Clinical endpoint